Structure Therapeutics Inc.

GPCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$36.81

+$1.81 (+5.17%)

At close: Sep 21, 2026, 4:00 PM ET

$36.90

+$0.09 (+0.24%)

Pre-market: Sep 22, 2026, 8:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.22M	1.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-1.22M	-1.22M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-258.07M	-209.89M	-176.56M	-247.61M	-219.66M	-182.52M	-158.23M	-142.16M	-122.47M	-115.14M	-102.78M	-84.74M	-71.29M	-59.26M	-52.56M	-52.88M	-40.19M	-26.23M	-13.27M
Interest Income	32.19M	41.15M	37.1M	29.23M	29.23M	27.6M	24M	19.55M	22.23M	17.7M	13.4M	8.08M	5.74M	3.02M	1.32M	425K	76K	1.91	1.91
Pretax Income	-214.36M	-169.96M	-140.69M	-210.2M	-178.49M	-142.94M	-122.22M	-110.69M	-100.26M	-97.44M	-89.38M	-76.62M	-65.51M	-56.23M	-51.3M	-52.52M	-40.18M	-26.3M	-13.28M
Net Income	-215.06M	-170.56M	-141.2M	-210.69M	-178.95M	-143.32M	-122.53M	-110.55M	-100.44M	-97.68M	-89.62M	-75.48M	-64.03M	-54.7M	-49.81M	-54.88M	-42.46M	-28.51M	-15.43M
Selling & General & Admin	73.81M	70.98M	61.55M	57.56M	56M	51.52M	49.41M	46.79M	42.18M	37.49M	32.67M	26.32M	21.22M	18.42M	16.37M	15.14M	11.61M	7.83M	3.37M
Research & Development	294.44M	249.09M	225.26M	190.05M	163.66M	131M	108.81M	95.37M	80.29M	77.65M	70.1M	58.42M	50.07M	40.84M	36.19M	37.74M	28.58M	18.4M	9.91M
Other Expenses	-111.4M	-111.4M	-110.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	256.85M	208.68M	176.56M	247.61M	219.66M	182.52M	158.23M	142.16M	122.47M	115.14M	102.78M	84.74M	71.29M	59.26M	52.56M	52.88M	40.19M	26.23M	13.27M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	69K	70K	70K	70K	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	258.07M	209.89M	176.56M	247.61M	219.66M	182.52M	158.23M	142.16M	122.47M	115.14M	102.78M	84.74M	71.29M	59.26M	52.56M	52.88M	40.19M	26.23M	13.27M
Income Tax Expense	702.57K	607.57K	515K	481K	465K	379K	310K	-138K	175K	240K	236K	368K	36K	-18K	17K	278K	205K	141K	81K
Shares Outstanding (Basic)	72.65M	72.44M	59.2M	58.49M	57.92M	57.35M	57.29M	57.21M	49.41M	46.57M	46.41M	38.32M	38.25M	37.42M	36.59M	39.12M	36.59M	36.59M	36.59M
Shares Outstanding (Diluted)	72.65M	72.44M	59.2M	58.49M	57.92M	57.35M	57.29M	57.21M	49.41M	46.57M	46.41M	38.32M	38.25M	37.42M	36.59M	39.12M	36.59M	36.59M	36.59M
EPS (Basic)	-3.03	-2.64	-2.40	-3.63	-3.12	-2.58	-2.34	-2.25	-2.28	-2.34	-2.25	-2.04	-2.67	-2.49	-2.37	-2.46	-1.20	-0.78	-0.42
EPS (Diluted)	-3.03	-2.64	-2.40	-3.63	-3.12	-2.58	-2.34	-2.25	-2.28	-2.34	-2.25	-2.04	-2.67	-2.49	-2.37	-2.46	-1.20	-0.78	-0.42
EBITDA	-212.44M	-167.74M	-139.42M	-209.08M	-177.38M	-141.9M	-121.22M	-109.9M	-99.66M	-96.99M	-89.09M	-76.33M	-65.22M	-55.96M	-50.96M	-52.18M	-39.91M	-26.09M	-13.21M
EBIT	-214.36M	-169.96M	-140.69M	-210.2M	-178.49M	-142.94M	-122.22M	-110.69M	-100.26M	-97.44M	-89.38M	-76.62M	-65.51M	-56.23M	-51.24M	-52.45M	-40.11M	-26.23M	-13.27M
Depreciation & Amortization	1.92M	2.21M	1.27M	1.13M	1.1M	1.04M	992K	791K	605K	447K	295K	295K	292K	277K	277K	271K	195K	136K	66K